Suppression of murine colitis by Kampo medicines, with special reference to the efficacy of saireito

[1]  J. Yamamoto-Furusho,et al.  Role of cytokines in inflammatory bowel disease. , 2008, World journal of gastroenterology.

[2]  Y. Zhuang,et al.  Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase , 2008, Digestive Diseases and Sciences.

[3]  Steven J Brown,et al.  The Immune Response in Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.

[4]  A. Ozcan,et al.  Hyperbaric Oxygen Enhances the Efficiency of 5-Aminosalicylic Acid in Acetic Acid–Induced Colitis in Rats , 2006, Digestive Diseases and Sciences.

[5]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[6]  Y. Kano,et al.  Pharmacological properties of traditional medicine (XXIX): effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. , 2004, Biological & pharmaceutical bulletin.

[7]  K. Terasawa,et al.  Two Cases of Ulcerative Colitis Successfully Treated with Kigi-kenchu-to , 2004 .

[8]  T. Hong,et al.  Evaluation of the Anti-Inflammatory Effect of Baicalein on Dextran Sulfate Sodium-Induced Colitis in Mice , 2002, Planta medica.

[9]  Hong Tie,et al.  Effect of components of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) on murine colitis induced by dextran sulfate sodium. , 2000 .

[10]  T. Kobayashi,et al.  Effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) on the murine colitis induced by dextran sulfate sodium , 2000 .

[11]  T. Sugiura,et al.  Sensitivity Difference to the Suppressive Effect of Prostaglandin E2 Among Mouse Strains: A Possible Mechanism to Polarize Th2 Type Response in BALB/c Mice , 2000, The Journal of Immunology.

[12]  S. Kitajima,et al.  Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. , 2000, Experimental animals.

[13]  M. McAlindon,et al.  Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease , 1998, Gut.

[14]  Z. Kmieć.  Cytokines in inflammatory bowel disease. , 1998, Archivum immunologiae et therapiae experimentalis.

[15]  木村 伊佐美,et al.  ラットにおけるデキストラン硫酸誘発潰瘍性大腸炎モデルに関する基礎的研究（第3報）―各種阻害剤の直腸内投与による影響― , 1996 .

[16]  H. Y. Zhou.  The effect of Orengedoku-to on the TNB-induced colitis , 1996 .

[17]  B. Volk,et al.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT‐PCR) , 1995, Clinical and experimental immunology.

[18]  T. Ohkusa,et al.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice , 1990 .

[19]  T. Ohkusa.  [Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora]. , 1985, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[20]  W. Stenson,et al.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models , 1984 .

[21]  R. Marcus,et al.  Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors. , 1974, Gastroenterology.